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RUNNING TITLE: MRSA SHOWS HIGH RATE OF MULTIDRUG RESISTANCE FROM CLINICAL ISOLATES 
ABSTRACT 
Infections of methicillin-resistant Staphylococcus aureus (MRSA) are becoming an increasingly concerning clinical problem. 
The aim of this study was to assess the development of multidrug resistant strains of MRSA from clinical samples 
andpossibilities for reducing resistance. This study included a total of seventy-five (75) isolates comprising fifteen (15) each 
collected from ear, urine, cervix, blood and wounds. An agar disc diffusion test was used to measure the effects of antimicrobial 
agents against the bacteria isolates following standardized guidelines. Out of a total of 75 clinical isolates of S. aureuscollected, 
43 (57.3%) were resistant to methicillin with isolates obtained from ear infections showing the highest resistance pattern of 
14.7% while the least was from urine sample with incidence of 5.3%. From the 43 isolates that showed resistance to methicillin, 
36 (83.7%) were multidrug resistant to various classes of antibiotics tested.MRSA showed an increasing trend of antimicrobial 
resistance and therefore calls for periodic surveillance of nosocomial infections due to S. aureus and other important bacterial 
pathogens. 
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Les infections Staphylococcus aureus résistant a la methicilline (MRSA) sont de plus en plus devenir une préoccupation 
clinique. Le but de cette recherche était d'évaluer le développement des souches multirésistantes de MRSA des échantillons 
clinique et les possibilités de réduire la résistance. Cette recherche a compris un total de soixante quinze (75) isolats comprenant 
quinze (15), chaque collecté de l'oreille, de l'urine, du col de l'utérus, du sang et des plaies. Un test de diffusion sur disque 
d'agar a été employé pour mesurer les effets des agents antimicrobiens contre les isolats bactériens selon les directives 
normalisées. Sur un total de 75 isolats cliniques de S. aureus collectés, 43 (57,3%) étaient résistants a  methicilline avec des isolats 
obtenus des infections de l'oreille montrant le profil de résistance le plus élevé de 14,7% tandis que le moins était de 
l'échantillon d'urine avec une incidence 5,3%. Des 43 isolats qui ont montré la résistance amethicilline, 36(83,7%) étaient 
multirésistants aux diverses classes d'antibiotiques testés. MRSA a montré une tendance de plus en plus de la résistance aux 
antimicrobiens et demande par conséquent la surveillance périodique des infections nosomicales due aS. aureus et d'autres 
agents pathogènes bactériens importants. 
 













Among all the antibiotic resistance achieved 
by Staphylococcus aureus, two most remarkable ones 
are methicillin and vancomycin resistance. The 
methicillin resistance was achieved by interspecies 
transfer ofmecA gene from an 
ancestral Staphylococcus species to S. aureus mediated 
by a unique staphylococcal mobile genetic element. 
Vancomycin resistance was achieved by horizontal 
transfer of a plasmid-bornvanA-gene transposon from 
vancomycin-resistant Enterococcus to S. aureus across 
the genus barrier. Practicallyall S. aureus isolates were 
methicillin susceptible until 1961, when Jevons found 
three MRSA strains among 5440 
clinical S. aureus strains in England (1). 
 
MRSA is born when methicillin-
susceptibleS. aureus (MSSA) has acquired the 
methicillin-resistance gene mecA by horizontal gene 
transfer mediated by a mobile genetic element 
staphylococcal cassette chromosome (SCC) (2).S. 
aureus colonizes various parts of healthyhumans such 
as the nares, skin, vagina andgastrointestinal tract (3). 
Its prevalence have beenseverally reported in healthy 
populations; 36% and40% were reported in women’s 
urine in two centresin Nigeria, 17.3% in nasal cavity 
of Turkish children,36% in nares of Japanese adults 
and 32.4% in nasalcavity of adults in USA (4-7). 
Colonizing strains mayserve as endogenous 
reservoirs for overt clinicalinfections or may spread to 
other patients. 
 
S. aureus have become resistant to 
variousantimicrobial agents including the commonly 
usedpenicillin-related antibiotics. Multi-drug 
resistantstrains of S. aureus have been reported 
withincreasing frequency worldwide. Strains that are 
resistant to methicillin were found to exhibit 
varyingresistance to lincosamides, 
macrolides,aminoglycosides, fluoroquinolones, or 
combinationsof these antibiotics (8, 9). Vancomycin – 
a glycopeptidewhich was initially very effective in the 
treatment ofMethicillin resistant S. aureus (MRSA) 
infections isrecently being witnessed with 
intermediate resistancefrom MRSA strains (10). 
In this study we hypothesize that the constant use of 
antibioticsin the hospitals could result in high amount 
of multidrug-resistant strains of MRSA 
 
STUDY AREA 
Clinical isolates of Staphylococcus aureusfrom patients’ 
samples were obtained from the Medical 
Microbiology Laboratory of the University of Benin 
Teaching Hospital, Benin City, Nigeria within a 3-





A total of seventy-five (75) isolates were collected 
comprising fifteen (15) each from ear, urine, cervix, 
blood and wounds. Identification and confirmation of 
isolates were conducted based on growth and 
fermentation on mannitol salt agar (MSA), colonial 
morphology, Gram staining and positive results to 
both catalase and coagulase tests (11). 
 
SUSCEPTIBILITY TEST 
The susceptibility of isolates to oxacillin using the E-
test strips (AB Biodisk) was carried out bythe disk 
diffusion method (12).Also tested were commercial 
antibiotics; amoxicillin 30µg, ampicillin/cloxacillin 
30µg, ceftriaxone 25µg, cefuroxime 20µg, 
ciprofloxacin 10µg, pefloxacin10µg, gentamicin 10µg, 
streptomycin 30µg, erythromycin 10µg and 
sulphamethoxazole/trimethoprim 30µg. Methicillin 
discs 5µg (Oxoid, England) was applied onto the Petri 
dish alongside with other tested antibiotics. A 
breakpoint of ≥2 µg was used to define resistance to 
oxacillin, zone diameter less than 14mm for 
methicillin while multidrug resistance was defined as 




Out of a total of seventy-five (75) clinical isolates of S. 
aureuscollected in this study, 43 representing 57.3% 
were resistant to methicillin. The distribution 
according to the site of isolation is shown in Table 1. 
Isolates obtained from ear infections showed the 
highest resistance pattern of 14.7% while the least was 
from urine sample with incidence of 5.3%.   Figure 1 
shows the resistance pattern of the various isolated to 
the antibiotic classes with multidrug resistance 
defined as resistance to three or more classes of 
antibiotics other than the beta-lactams. From the 43 
isolates that showed resistance to methicillin, 36 
(83.7%) were multidrug resistant. 
 
TABLE 1: PREVALENCE OF MRSA FROM DIFFERENT 
CLINICAL SAMPLE 
Site No. of S. aureus             No. resistant to  
isolates   methicillin/                
oxacillinPercentage(%) 
   
Ear 15  11       14.7  
    
Cervix 15  10       13.3  
     
Urine 15  4         5.3  
   
Blood 15  10       13.3  
 
Wound 15  8       10.7  
    





FIGURE 1: RESISTANCE PATTERN OF ISOLATES TO THE VARIOUS ANTIBIOTICS TESTED.




Infections caused by multi-resistant strains of 
aureus are identified by their resistance to methicillin. 
MRSA by definition is any strain of S. aureus 
developed resistance to beta-lactam antibiotics which 
include beta-lactam stable formulation
methicillin, oxacillin, flucloxacillin, nafcillin and 
cephalosporin. These MRSA strains are often 
responsible for several difficult to treat infections in 
humans (13). Knowledge of epidemiology of bacterial 
infections is very important for approp
making in the treatment of infections, such as 
septicemia, wound infections, and postsurgical 
infections. Irohaet al. (14) investigated cases among 
neonates in Lagos, Nigeria, in a prospective study. 
The incidence was 18 per 1,000 live birth
(37.4%) was the predominant etiologic pathogen 
among the bacteria. Another study investigated the 
bacteriology of nonsurgical wound infections in 
Ibadan. S. aureus (38%) was the predominant 
pathogen, followed by gram-negative bacteria (7 to 
19% each). High rates of antibiotic resistance were 
recorded among these isolates (15). 
The prevalence of MRSA in our study was higher 
(57.3%) compared to those in previous studies in 
South-westernNigeria. However, it should be 
considered that the presence of themecA
is the “gold standard” for determining methicillin
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A recent multicentre study in South
Nigeriaconfirmed resistance to methicillin by the 
detection of themecA gene by PCR and reported a 
lower prevalence rate of1.4% (16). Obasuyi also used 
molecular techniques and reported the prevalence of 
11% MRSA from clinical samples with two PFGE 
types (17). 
Despite the high MRSA rate in our study, it is 
evidentthat multidrug resistant strains occurred 
frequently in South-western Nigeria. However, the 
MRSA isolates were predominantly associated with 
infections (57.3%), since all isolates were from 
clinicalsamples as also observed in other studies 
elsewhere (27). Nevertheless, the p
was higher in this study than that Taiwo
which showed the rate of 29%. 
 
A major problem in the treatment of 
aureusinfections is the multidrug resistance pattern of 
thepathogen to a number of antibiotics. In the last 
fewyears, understanding of the genetic basis 
formethicillin resistance has advanced 
significantly.Multi-resistant MRSA have been 
reported to be relatively high in African countries 
including Morocco, Kenya and Cameroun (19). A 
majority of the MRSA in our study sho
resistance (83.7%). The misuse and misapplication of 
many antimicrobial agents in many parts of Nigeria 
may contribute to the high MRSA rate in this 
community. This poses a significant difficulty in 
antimicrobial agent choice for patients wit
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surveillance of nosocomial infections due to S. aureus 
and other important bacterial pathogen in order to 
minimize microbial transmission. 
 
CONCLUSIONEffort must therefore be put in place 
at control measures that should include a renewed 
awareness, isolation of MRSA infected patients in 
hospitals and multidrug resistance surveillance and 
enforcement of empiric use of antimicrobial agents to 
stem the tide of MRSA 
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